Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Sweet

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Synapse (New York, N.Y.)|November 24, 1998
Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brainG S Smith, J C Price, B J Lopresti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
Molecular Psychiatry|October 19, 2011
Genome-wide association analysis of age-at-onset in Alzheimer's diseaseM I Kamboh, M M Barmada, F Y Demirci, et al.
Neurology|April 28, 2012
Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memoryS Barral, T Bird, A Goate, et al.
Molecular Psychiatry|February 2, 2021
MAP2 is differentially phosphorylated in schizophrenia, altering its functionM J Grubisha, X Sun, M L MacDonald, et al.
Molecular Psychiatry|March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Molecular Psychiatry|May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Translational Psychiatry|July 27, 2012
Genome-wide association study of Alzheimer's diseaseM I Kamboh, F Y Demirci, X Wang, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Synapse (New York, N.Y.)|November 24, 1998
Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brainG S Smith, J C Price, B J Lopresti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
Molecular Psychiatry|October 19, 2011
Genome-wide association analysis of age-at-onset in Alzheimer's diseaseM I Kamboh, M M Barmada, F Y Demirci, et al.
Neurology|April 28, 2012
Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memoryS Barral, T Bird, A Goate, et al.
Molecular Psychiatry|February 2, 2021
MAP2 is differentially phosphorylated in schizophrenia, altering its functionM J Grubisha, X Sun, M L MacDonald, et al.
Molecular Psychiatry|March 14, 2019
Correction: Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Molecular Psychiatry|May 3, 2017
Genetic risk for schizophrenia and psychosis in Alzheimer diseaseM A A DeMichele-Sweet, E A Weamer, L Klei, et al.
Translational Psychiatry|July 27, 2012
Genome-wide association study of Alzheimer's diseaseM I Kamboh, F Y Demirci, X Wang, et al.
Pageof 8